Literature DB >> 10095856

Molecular mechanisms of vestibular compensation in the central vestibular system--review.

T Kitahara1, N Takeda, H Kiyama, T Kubo.   

Abstract

Vestibular compensation consists of two stages: the inhibition of the contralesional medial vestibular nucleus (contra-MVe) activities at the acute stage after unilateral labyrinthectomy (UL) and the recovery and maintenance of the ipsilesional MVe (ipsi-MVe) spontaneous activities at the chronic stage after UL. In this paper, we reviewed molecular mechanisms of vestibular compensation in the central vestibular system using several morphological and pharmacological approaches in rats. Based on our examinations, we propose the following hypotheses: i) at the acute stage after UL, the activated neurons in the ipsi-MVe project their axons into the flocculus to inhibit the contra-MVe neurons via the NMDA receptor, nitric oxide (NO) and/or GABA-mediated signalling, resulting in the restoration of balance between intervestibular nuclear activities. ii) At the chronic stage after UL, the flocculus depresses the inhibitory effects on the ipsi-MVe neurons via protein phosphatase 2A (PP2A) beta, protein kinase C (PKC) and glutamate receptor (GluR) delta-2, to help the recovery and maintenance of ipsi-MVe activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10095856

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  13 in total

1.  Asymmetric recovery in cerebellar-deficient mice following unilateral labyrinthectomy.

Authors:  M Beraneck; J L McKee; M Aleisa; K E Cullen
Journal:  J Neurophysiol       Date:  2008-05-28       Impact factor: 2.714

2.  Effects of Anti-NMDA Antibodies on Functional Recovery and Synaptic Rearrangement Following Hemicerebellectomy.

Authors:  Daniela Laricchiuta; Virve Cavallucci; Debora Cutuli; Paola De Bartolo; Paola Caporali; Francesca Foti; Carsten Finke; Marcello D'Amelio; Mario Manto; Laura Petrosini
Journal:  Neuromolecular Med       Date:  2016-03-30       Impact factor: 3.843

3.  Bayesian quantification of sensory reweighting in a familial bilateral vestibular disorder (DFNA9).

Authors:  Bart B G T Alberts; Luc P J Selen; Wim I M Verhagen; Ronald J E Pennings; W Pieter Medendorp
Journal:  J Neurophysiol       Date:  2017-12-13       Impact factor: 2.714

4.  Rapid compensatory changes in GABA receptor efficacy in rat vestibular neurones after unilateral labyrinthectomy.

Authors:  T Yamanaka; A Him; S A Cameron; M B Dutia
Journal:  J Physiol       Date:  2000-03-01       Impact factor: 5.182

5.  The Dizziness Handicap Inventory does not correlate with vestibular function tests: a prospective study.

Authors:  Chun Wai Yip; Michael Strupp
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

6.  An in situ hybridization and immunofluorescence study of GABA(A) and GABA(B) receptors in the vestibular nuclei of the intact and unilaterally labyrinthectomized rat.

Authors:  Lyndell Eleore; Isabelle Vassias; Isabelle Bernat; Pierre-Paul Vidal; Catherine de Waele
Journal:  Exp Brain Res       Date:  2004-09-25       Impact factor: 1.972

7.  Role of the commissural inhibitory system in vestibular compensation in the rat.

Authors:  Filip Bergquist; Mike Ludwig; Mayank B Dutia
Journal:  J Physiol       Date:  2008-07-17       Impact factor: 5.182

8.  Reconsidering the role of neuronal intrinsic properties and neuromodulation in vestibular homeostasis.

Authors:  Mathieu Beraneck; Erwin Idoux
Journal:  Front Neurol       Date:  2012-02-28       Impact factor: 4.003

9.  Changes in Histamine Receptors (H1, H2, and H3) Expression in Rat Medial Vestibular Nucleus and Flocculus after Unilateral Labyrinthectomy: Histamine Receptors in Vestibular Compensation.

Authors:  Liuqing Zhou; Wen Zhou; Sulin Zhang; Bo Liu; Yangming Leng; Renhong Zhou; Weijia Kong
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Plasticity of histamine H3 receptor expression and binding in the vestibular nuclei after labyrinthectomy in rat.

Authors:  Adrian F Lozada; Antti A Aarnisalo; Kaj Karlstedt; Holger Stark; Pertti Panula
Journal:  BMC Neurosci       Date:  2004-09-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.